ANDA 90018, held by Sun Pharma Global. Zoledronic Acid.
As of Nov 14, 2026, ANDA 90018 (Zoledronic Acid), held by Sun Pharma Global, was first approved by FDA on Mar 4, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 4, 2013 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Zoledronic AcidEQ 4MG BASE/VIAL ยท injectable;intravenous | Zoledronic Acid | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
